Nundina › Discover calendars › FDA New Drug Approvals calendar › FDA approves Weltruza (olanzapine)FDA approves Weltruza (olanzapine)8 October 2026The FDA approved Weltruza (olanzapine), a drug from Teva Neuroscience Inc. Form: Suspension, Extended Release, Injectable. Application NDA219007.FDA New Drug Approvals calendarMore from this calendar

19 October 2026 - FDA approves Calrezdy (calcuim chloride)

19 October 2026 - FDA approves Cienby (sodium ctirate)

16 October 2026 - FDA approves Yulzety (rivaroxaban)

16 October 2026 - FDA approves Brytly (brytly (apraclonidine))

15 October 2026 - FDA approves Evoxac (cevimeline hydrochloride)